All News

Although a recent study revealed shortcomings associated with ChatGPT and its guidance on medication use, it doesn’t rule out its potential as a valuable health care tool.

Academic, corporate, and clinical institutions must empower pharmacists to deliver informed and compassionate care to LGBTQ individuals that matches the standard received by their heterosexual and cisgender peers.

In abstracts presented at the 2024 American Society of Clinical Oncology’s annual meeting, researchers addressed the association between heart failure and multiple types of cancers.

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

The therapy from AstraZeneca is indicated to improve glycemic control in patients aged 10 years or older.

The Supreme Court ruled on the question of limiting access to to mifepristone, a key abortion drug that anti-abortion groups have been working to limit across the country.

The APhA urged policy makers to consider these recommendations to avoid further exacerbating effects of the attack on US health systems.

Patrick Alonso, PharmD, CPh, discusses how pharmacists can support men dealing with mental health issues and lifestyle changes he recommends to male patients to improve overall health.

In a world rich with diversity, pharmacists need to understand how varied backgrounds and special needs can impact a patient’s decisions in managing their health and medication protocols.

Patients with advanced cancer can experience malignant wounds, which can have a negative impact on quality of life.

Patrick Alonso, PharmD, CPh, owner and manager of BlueZone Health Care Advocates and co-host of the Men’s Health Unscripted podcast, talks about how health care providers can build trust with male patients and what screenings men at different ages should be having.

CDC researchers reported on the improvements and inaccuracies of assays within the Vitamin D Standardization-Certification Program.

As the opioid crisis and injection drug use continue, pharmacists can look to previous outbreaks to guide their responses to the HIV–injection drug use syndemic.

The Lingo and Libre Rio from Abbott are based on the company’s FreeStyle Libre sensing technology.

Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, discusses how some of the concern’s raised by the panel can inform future psychedelic research.

The new task force highlights a stronger government focus on curbing the risks of e-cigarettes for young people, especially after sustained calls for stricter action on the public health issue by lawmakers and the public.

In a study presented at ASCO 2024, investigators found that all 20 included patients with early stage breast cancer receiving chemotherapy developed hyperglycemia.

See what’s trending in pharmacy with a preview of the Drug Topics June issue.

Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, talks about some of the problems he saw during the Psychopharmacologic Drugs Advisory Committee meeting.

“The more we share our experiences and stories and work together as a profession, the more we can come together to support each other and form solutions,” said Joanna Lewis, PharmD, MBA, wellness writer and advocate, on overcoming burnout in the pharmacy.

Check out this recap of articles published on our sister sites during the past week.

Check out important updates from the FDA for the week of June 3.

In a session presented at the 2024 Heart in Diabetes Conference, researchers discussed the abilities of continuous glucose monitoring (CGM) to capture lifestyle data and improve mortality rates.

Vaccinated men and women are at a reduced risk for HPV-related cancers, according to research presented at ASCO 2024.

In an abstract presented at ENDO 2024, researchers addressed practitioners’ current knowledge of CGM and their experience prescribing in low-income communities.

HbA1c levels decreased significantly after an average of 154 days in patients who used a continuous glucose monitor.

Four poster presented at ENDO 2024 examined the current landscape of diabetes.

The Psychopharmacologic Drugs Advisory Committee voted 10-1 that the benefits of MDMA do not outweigh its potential risks.